These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15670368)

  • 21. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraventricular Hemorrhage Caused by Subarachnoid Hemorrhage: Does the Severity Matter?
    Darkwah Oppong M; Gembruch O; Herten A; Frantsev R; Chihi M; Dammann P; El Hindy N; Forsting M; Sure U; Jabbarli R
    World Neurosurg; 2018 Mar; 111():e693-e702. PubMed ID: 29305915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage.
    Staykov D; Huttner HB; Struffert T; Ganslandt O; Doerfler A; Schwab S; Bardutzky J
    Stroke; 2009 Oct; 40(10):3275-80. PubMed ID: 19679848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.
    Pollock GA; Shaibani A; Awad I; Batjer HH; Bendok BR
    Neurosurgery; 2011 Feb; 68(2):E581-6; discussion E586. PubMed ID: 21654560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial.
    Naff NJ; Hanley DF; Keyl PM; Tuhrim S; Kraut M; Bederson J; Bullock R; Mayer SA; Schmutzhard E
    Neurosurgery; 2004 Mar; 54(3):577-83; discussion 583-4. PubMed ID: 15028130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the Ommaya Reservoir in Managing Ventricular Hemorrhage.
    Yang XT; Feng DF; Zhao L; Sun ZL; Zhao G
    World Neurosurg; 2016 May; 89():93-100. PubMed ID: 26724628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period.
    Cesarini KG; Hårdemark HG; Persson L
    J Neurosurg; 1999 Apr; 90(4):664-72. PubMed ID: 10193611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage.
    Goh KY; Poon WS
    Surg Neurol; 1998 Dec; 50(6):526-31; discussion 531-2. PubMed ID: 9870812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and feasibility of combined coiling and neuroendoscopy for better outcomes in the treatment of severe subarachnoid hemorrhage accompanied by massive intraventricular hemorrhage.
    Iwaasa M; Ueba T; Nonaka M; Okawa M; Abe H; Higashi T; Inoue T
    J Clin Neurosci; 2013 Sep; 20(9):1264-8. PubMed ID: 23830690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study.
    Seifert V; Stolke D; Zimmermann M; Feldges A
    Acta Neurochir (Wien); 1994; 128(1-4):137-43. PubMed ID: 7847131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 35. Intraventricular tissue plasminogen activator for intraventricular hemorrhage caused by an arteriovenous malformation.
    Keefe K; Kebriaei M; Gard A; Patil AA
    J Clin Neurosci; 2014 Mar; 21(3):526-9. PubMed ID: 24134809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intracerebral hemorrhage.
    Hwang BY; Bruce SS; Appelboom G; Piazza MA; Carpenter AM; Gigante PR; Kellner CP; Ducruet AF; Kellner MA; Deb-Sen R; Vaughan KA; Meyers PM; Connolly ES
    J Neurosurg; 2012 Jan; 116(1):185-92. PubMed ID: 21999319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which side of lateral ventricles to choose during external ventricular drainage in patients with intraventricular hemorrhage: ipsilateral or contralateral?
    Wang K; Du HG; Yin LC; He M; Hao BL; Chen L
    J Surg Res; 2013 Aug; 183(2):720-5. PubMed ID: 23535113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
    Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
    Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage.
    Qureshi AI; Suri MF; Sung GY; Straw RN; Yahia AM; Saad M; Guterman LR; Hopkins LN
    Neurosurgery; 2002 Apr; 50(4):749-55; discussion 755-6. PubMed ID: 11904025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.